scholarly journals Dispositivos de monitoramento: aliados ou inimigos? construindo um protocolo de limpeza/desinfecção para enfermagem

2019 ◽  
Vol 81 (19) ◽  
Author(s):  
Roberta Pereira Spala Neves ◽  
Fátima Helena do Espirito Santo

Este estudo aborda a limpeza e desinfecção dos principais dispositivos não-críticos de monitoração, considerandosua participação na transmissão das infecções relativas aos cuidados médicos. O objetivo deste estudo é descrevero desenvolvimento de um protocolo de limpeza e desinfecção dos principais dispositivos não-críticos utilizados namonitorização, baseado em melhores práticas, evidenciadas na literatura. É um estudo descritivo e exploratório,guiado pela pesquisa baseada em evidência, conduzida de Março de 2012 à Julho de 2014, explorando as seguintesfases: uma revisão integrativa de literatura; preparação de protocolo de desinfecção e limpeza de dispositivos nãocríticos de monitoramento e avaliação por experts. Entre as boas práticas encontradas na literatura sobre limpezae desinfecção destes dispositivos destaca-se o uso do álcool etílico à 70% como desinfetante principal da escolhada necessidade, utilizado em intervalos regulares. O protocolo foi avaliado por um painel de peritos, incluindo nestaavaliação a possibilidade de aplicação no contexto dos cuidados médicos nas instituições de saúde. Acredita-se queeste protocolo possa contribuir como guia das práticas profi ssionais de saúde, minimizando os riscos de infecçõesno cotidiano do serviço de saúde.Palavras-chave: Termômetros; Esfi gnomômetros; Eletrocardiografi a; Oximetria; Infecção Hospitalar. ABsTRAcTThis study approaches the cleaning and disinfection of the main non-critical monitoring devices, consideringtheir participation in the transmission of infections related to health care and the goal this study is describe thedevelopment of a cleaning protocol and disinfection of the main non-critical monitoring devices based on bestpractices and evidence from the literature. It is a descriptive and exploratory study, guided by evidence-basedresearch, conducted from March 2012 to July 2014 in the following stages: an integrative literature review,preparation of non-critical cleaning protocol and disinfection monitoring devices and evaluation expertise.Among the good practices identifi ed in the literature on cleaning and disinfection of these devices includethe use of ethanol to 70% as the main disinfectant of choice and the need for cleaning and disinfection ofthese devices at regular intervals, set the protocol that was assessed by the experts as appropriate panel withapplication possibility in the healthcare context of health institutions. We believe that this protocol may contributeto guide health professional’s practices minimize the risk of infection associated with their use in everyday healthservices.Keywords: Thermometers; Sphygmomanometers; Electrocardiography; Oximetry; Hospital Infection.

2018 ◽  
Vol 9 (4) ◽  
pp. 466-481 ◽  
Author(s):  
Matias Escuder ◽  
Martin Tanco ◽  
Anabella Santoro

PurposeThis paper aims to outline the barriers in introducing Lean in health care and to asses which of these have a greater impact in the Uruguayan health-care sector.Design/methodology/approachTo uncover the barriers hindering Lean health-care implementation, a literature review was undertaken. Once identified, first-hand information was obtained from managers and professionals involved in managerial activities who evaluated each of the difficulties using a Likert scale.FindingsIn total, 17 barriers to the implementation of Lean health care were identified. Survey results show that the highest scores correspond to “controllable” barriers, those which can be overcome, almost exclusively, by the organization willing to implement the program.Practical implicationsManagers need to understand and ascertain the existing barriers before implementing Lean if they want to develop strategies to mitigate them. Although the exploratory study was conducted in the Uruguayan health-care sector, it could be replicated elsewhere.Originality/valueAn exhaustive list of barriers was synthesized and was later assessed by managers in the Uruguayan context. This is an important first step that could help foresee obstacles and develop strategies prior future implementation.


2017 ◽  
Vol 41 (3) ◽  
pp. 222-233 ◽  
Author(s):  
David J. Bumgarner ◽  
Elizabeth J. Polinsky ◽  
Katharine G. Herman ◽  
Joanne M. Fordiani ◽  
Carmen P. Lewis ◽  
...  

2011 ◽  
Vol 8 (1) ◽  
Author(s):  
Elizabeth Jacobs ◽  
Emily Mendenhall ◽  
Ann Scheck-McAlearney ◽  
Italia Rolle ◽  
Eric Whitaker ◽  
...  

2021 ◽  
pp. 003435522098079
Author(s):  
Emre Umucu ◽  
Beatrice Lee ◽  
Veronica Estala-Gutierrez ◽  
Timothy Tansey

The purpose of this exploratory study was to examine whether demographic and disability variables predict total health care expenditure of Wisconsin PROMISE. The findings are intended to assist in promoting cost-effectiveness for future similar initiates. This study data were extracted from Wisconsin PROMISE data set. This study had a total of 1,443 youth with disabilities ( Mage = 14.89). The majority of participants were male (69%). Our results indicated that some demographic and disability–related characteristics are associated with total health care expenditure in control with VR case during PROMISE, control without VR case during PROMISE, and treatment group. Overall, findings of the current study suggest demographic and disability variables do assist in predicting total health care expenditure of Wisconsin PROMISE.


2020 ◽  
Vol 13 (11) ◽  
pp. 400
Author(s):  
Arnold G. Vulto ◽  
Jackie Vanderpuye-Orgle ◽  
Martin van der Graaff ◽  
Steven R. A. Simoens ◽  
Lorenzo Dagna ◽  
...  

Introduction: Biosimilars have the potential to enhance the sustainability of evolving health care systems. A sustainable biosimilars market requires all stakeholders to balance competition and supply chain security. However, there is significant variation in the policies for pricing, procurement, and use of biosimilars in the European Union. A modified Delphi process was conducted to achieve expert consensus on biosimilar market sustainability in Europe. Methods: The priorities of 11 stakeholders were explored in three stages: a brainstorming stage supported by a systematic literature review (SLR) and key materials identified by the participants; development and review of statements derived during brainstorming; and a facilitated roundtable discussion. Results: Participants argued that a sustainable biosimilar market must deliver tangible and transparent benefits to the health care system, while meeting the needs of all stakeholders. Key drivers of biosimilar market sustainability included: (i) competition is more effective than regulation; (ii) there should be incentives to ensure industry investment in biosimilar development and innovation; (iii) procurement processes must avoid monopolies and minimize market disruption; and (iv) principles for procurement should be defined by all stakeholders. However, findings from the SLR were limited, with significant gaps on the impact of different tender models on supply risks, savings, and sustainability. Conclusions: A sustainable biosimilar market means that all stakeholders benefit from appropriate and reliable access to biological therapies. Failure to care for biosimilar market sustainability may impoverish biosimilar development and offerings, eventually leading to increased cost for health care systems and patients, with fewer resources for innovation.


Sign in / Sign up

Export Citation Format

Share Document